Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies

Introduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of th...

Full description

Bibliographic Details
Main Authors: Leonor Asensio-Aguerri, Luis Beato-Fernández, Maria Stavraki, Teresa Rodríguez-Cano, Miriam Bajo, Darío Díaz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Psychology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/full
_version_ 1811274113440808960
author Leonor Asensio-Aguerri
Luis Beato-Fernández
Luis Beato-Fernández
Maria Stavraki
Teresa Rodríguez-Cano
Teresa Rodríguez-Cano
Miriam Bajo
Darío Díaz
author_facet Leonor Asensio-Aguerri
Luis Beato-Fernández
Luis Beato-Fernández
Maria Stavraki
Teresa Rodríguez-Cano
Teresa Rodríguez-Cano
Miriam Bajo
Darío Díaz
author_sort Leonor Asensio-Aguerri
collection DOAJ
description Introduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of the impact of these pathological thoughts on positive health, studying the well-being of people who experience paranoid thoughts is fundamental. The first objective of this research is to apply the Complete State Model of Health (CSMH) to a sample of patients characterized by the presence of paranoid thinking. Our second objective is to evaluate the impact of therapies based on reducing pathological confidence on patients’ well-being.MethodsSixty participants with SCID-5 confirmed DSM-5 diagnosis related with paranoid thinking and without mood symptoms were recruited. In order to test the existence of a two continua model of mental health (CSMH), we conducted a parallel analysis and an exploratory factor analysis. To test our hypothesis regarding the partially mediating role of doubt between paranoid thinking and patients’ well-being, we conducted a biased corrected bootstrapping procedure.ResultsAs expected, two different unipolar dimensions emerged from the measures used to assess paranoid thinking and positive health (two continua model of mental health). When patients received metacognitive and pharmacological treatment, more paranoid thinking led to more doubt in all thoughts, which in turn affected well-being. The analyses carried out confirmed the partial mediating role of doubt.ConclusionDespite the efficacy shown by both metacognitive therapies and antipsychotics, it seems that they not only reduce pathological confidence, but can also affect other thoughts not linked to delirium. This effect of generalization of doubt in all thoughts negatively affected patients’ well-being and quality of life.
first_indexed 2024-04-12T23:13:14Z
format Article
id doaj.art-c406c34ee3bf47cbab622dc2d9c14ede
institution Directory Open Access Journal
issn 1664-1078
language English
last_indexed 2024-04-12T23:13:14Z
publishDate 2019-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychology
spelling doaj.art-c406c34ee3bf47cbab622dc2d9c14ede2022-12-22T03:12:45ZengFrontiers Media S.A.Frontiers in Psychology1664-10782019-09-011010.3389/fpsyg.2019.02099464977Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive TherapiesLeonor Asensio-Aguerri0Luis Beato-Fernández1Luis Beato-Fernández2Maria Stavraki3Teresa Rodríguez-Cano4Teresa Rodríguez-Cano5Miriam Bajo6Darío Díaz7Mental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainMental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainMental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainIntroduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of the impact of these pathological thoughts on positive health, studying the well-being of people who experience paranoid thoughts is fundamental. The first objective of this research is to apply the Complete State Model of Health (CSMH) to a sample of patients characterized by the presence of paranoid thinking. Our second objective is to evaluate the impact of therapies based on reducing pathological confidence on patients’ well-being.MethodsSixty participants with SCID-5 confirmed DSM-5 diagnosis related with paranoid thinking and without mood symptoms were recruited. In order to test the existence of a two continua model of mental health (CSMH), we conducted a parallel analysis and an exploratory factor analysis. To test our hypothesis regarding the partially mediating role of doubt between paranoid thinking and patients’ well-being, we conducted a biased corrected bootstrapping procedure.ResultsAs expected, two different unipolar dimensions emerged from the measures used to assess paranoid thinking and positive health (two continua model of mental health). When patients received metacognitive and pharmacological treatment, more paranoid thinking led to more doubt in all thoughts, which in turn affected well-being. The analyses carried out confirmed the partial mediating role of doubt.ConclusionDespite the efficacy shown by both metacognitive therapies and antipsychotics, it seems that they not only reduce pathological confidence, but can also affect other thoughts not linked to delirium. This effect of generalization of doubt in all thoughts negatively affected patients’ well-being and quality of life.https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/fullwell-beingquality of lifeparanoid thinkingdoubtComplete State Model of Health
spellingShingle Leonor Asensio-Aguerri
Luis Beato-Fernández
Luis Beato-Fernández
Maria Stavraki
Teresa Rodríguez-Cano
Teresa Rodríguez-Cano
Miriam Bajo
Darío Díaz
Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
Frontiers in Psychology
well-being
quality of life
paranoid thinking
doubt
Complete State Model of Health
title Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
title_full Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
title_fullStr Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
title_full_unstemmed Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
title_short Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
title_sort paranoid thinking and wellbeing the role of doubt in pharmacological and metacognitive therapies
topic well-being
quality of life
paranoid thinking
doubt
Complete State Model of Health
url https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/full
work_keys_str_mv AT leonorasensioaguerri paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT luisbeatofernandez paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT luisbeatofernandez paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT mariastavraki paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT teresarodriguezcano paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT teresarodriguezcano paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT miriambajo paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies
AT dariodiaz paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies